The "US Scleroderma Market and Competitive Landscape – 2021" report has been added to ResearchAndMarkets.com’s offering. US Scleroderma Market and Competitive Landscape Highlights – 2021, provides ...
More than a decade after first approving Actemra (tocilizumab) for the treatment of rheumatoid arthritis, the FDA has added a sixth use to its label: slowing the rate of decline in pulmonary function ...
Most people with scleroderma have autoantibodies. Several scleroderma-specific antibodies have been identified. These can help with diagnosis and give insight into the type of disease you may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results